Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS3W
Performance in the last:
Follow this Portfolio
1D -0.7 %
1W 0.0 %
2W 0.1 %
1M -0.8 %
3M -0.8 %
6M 3.1 %
9M -38.2 %
1Y -37.5 %
Alpha
-54.2%
Beta
0.52
sharpe-R
-0.73
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.97
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-10-18 07:52:26
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -50.18%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.69% 4.23%
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.62% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.5% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.63% -3.37%
CDXS Codexis, Inc. Buy 6.82% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.65% -3.09%
VREX Varex Imaging Corporation Buy 6.4% 0%
NKTR Nektar Therapeutics Buy 6.4% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.4% 0%
AXSM Axsome Therapeutics, Inc. Buy 6.4% 0%
CUTR Cutera, Inc. Sell -3.3% 12%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.35%
BHVN Biohaven Ltd. Sell -3.96% -0.33%
The percentage of cash held in the portfolio is: 34%
** The description of each asset is available Here

The latest 5 Compositions change

2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.69% 4.23%
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.62% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.5% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.63% -3.37%
CDXS Codexis, Inc. Buy 6.82% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.65% -3.09%
VREX Varex Imaging Corporation Buy 6.4% 0%
NKTR Nektar Therapeutics Buy 6.4% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.4% 0%
AXSM Axsome Therapeutics, Inc. Buy 6.4% 0%
CUTR Cutera, Inc. Sell -3.3% 12%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.35%
BHVN Biohaven Ltd. Sell -3.96% -0.33%
The percentage of cash held in the portfolio is: 34%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.66% 5.63%
ORGO Organogenesis Holdings Inc. Buy 7.14% 5.52%
ARDX Ardelyx, Inc. Buy 6.53% -3.15%
BKD Brookdale Senior Living Inc. Buy 7.44% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.35% 8.99%
VCEL Vericel Corporation Buy 6.61% -1.95%
RDNT RadNet, Inc. Buy 6.72% -0.34%
CDXS Codexis, Inc. Buy 7% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 6.89% 2.27%
CUTR Cutera, Inc. Sell -3.34% 9.25%
FATE Fate Therapeutics, Inc. Sell -3.68% 0%
IRTC iRhythm Technologies, Inc. Sell -3.64% 1.5%
AXSM Axsome Therapeutics, Inc. Sell -3.84% -3.9%
BHVN Biohaven Ltd. Sell -3.87% 0%
The percentage of cash held in the portfolio is: 56.03%
New Assets Added
  • BHVN
Assets Removed
Asset Action Perf %
ORMP Buy All -1.67%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.57% 3.05%
ORGO Organogenesis Holdings Inc. Buy 7.1% 3.9%
ARDX Ardelyx, Inc. Buy 6.73% -1.16%
BKD Brookdale Senior Living Inc. Buy 6.83% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.99% 2.69%
VCEL Vericel Corporation Buy 6.79% -0.33%
RDNT RadNet, Inc. Buy 6.82% 0.2%
CDXS Codexis, Inc. Buy 6.81% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.81% 0%
CUTR Cutera, Inc. Sell -3.42% 8%
FATE Fate Therapeutics, Inc. Sell -3.53% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.66% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.58% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -3.73% 0.18%
The percentage of cash held in the portfolio is: 56.47%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.45% 0.7%
ORGO Organogenesis Holdings Inc. Buy 6.9% 0.32%
ARDX Ardelyx, Inc. Buy 6.79% -0.83%
BKD Brookdale Senior Living Inc. Buy 6.85% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.85% 0%
VCEL Vericel Corporation Buy 6.85% 0%
RDNT RadNet, Inc. Buy 6.85% 0%
CUTR Cutera, Inc. Sell -3.54% 5.33%
FATE Fate Therapeutics, Inc. Sell -3.55% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.72% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.47% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -3.7% 1.35%
The percentage of cash held in the portfolio is: 70.46%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
ORGO Organogenesis Holdings Inc. Buy 6.88% -0.32%
ARDX Ardelyx, Inc. Buy 6.87% 0%
CUTR Cutera, Inc. Sell -3.8% -1.33%
FATE Fate Therapeutics, Inc. Sell -3.61% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -3.74% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.43% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -3.81% -1.12%
The percentage of cash held in the portfolio is: 98.21%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.34% -1.17%
ORGO Organogenesis Holdings Inc. Buy 6.75% -1.95%
CUTR Cutera, Inc. Sell -3.64% 2.67%
FATE Fate Therapeutics, Inc. Sell -3.43% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -3.76% -0.42%
IRTC iRhythm Technologies, Inc. Sell -3.44% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -3.61% 4.05%
The percentage of cash held in the portfolio is: 104.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.48% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.89% 0%
ORGO Organogenesis Holdings Inc. Buy 6.89% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -3.68% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.76% 0%
AXSM Axsome Therapeutics, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 98.45%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.75% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 104.82%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Buy All 16.11%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 7.18% -8.98%
CERS Cerus Corporation Sell -3.46% 14.69%
The percentage of cash held in the portfolio is: 96.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 7.57% -3.32%
MYGN Myriad Genetics, Inc. Buy 7.61% 2.48%
CERS Cerus Corporation Sell -3.43% 14.69%
The percentage of cash held in the portfolio is: 88.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -8.2%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 8.54% -4.92%
NVCR NovoCure Limited Buy 7.59% -2.44%
MYGN Myriad Genetics, Inc. Buy 7.79% 5.56%
CERS Cerus Corporation Sell -3.38% 15.64%
The percentage of cash held in the portfolio is: 79.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
LMAT Buy All 0.21%
AVXL Buy All 6.46%
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.83% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -2.73%
NVCR NovoCure Limited Buy 7.77% -0.17%
MYGN Myriad Genetics, Inc. Buy 7.82% 6.04%
LMAT LeMaitre Vascular, Inc. Sell -3.72% 0.25%
AVXL Anavex Life Sciences Corp. Sell -3.47% 7.14%
CERS Cerus Corporation Sell -3.73% 6.64%
The percentage of cash held in the portfolio is: 76.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.82% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.69% -3.83%
NVCR NovoCure Limited Buy 7.79% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.68% 3.45%
STAA STAAR Surgical Company Sell -3.7% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.64% 3.06%
CERS Cerus Corporation Sell -3.93% 2.37%
The percentage of cash held in the portfolio is: 81.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.31% 1.14%
PODD Insulet Corporation Buy 9.82% 12.73%
MGNX MacroGenics, Inc. Buy 9.43% 2.85%
ESPR Esperion Therapeutics, Inc. Buy 8.77% -4.37%
TVTX Travere Therapeutics, Inc. Buy 9.26% 31.25%
NVCR NovoCure Limited Buy 7.63% -3.99%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.15%
STAA STAAR Surgical Company Sell -3.58% 7.41%
LMAT LeMaitre Vascular, Inc. Sell -3.77% 0.97%
AVXL Anavex Life Sciences Corp. Sell -3.38% 11.39%
CERS Cerus Corporation Sell -3.95% 3.32%
The percentage of cash held in the portfolio is: 56.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.13% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.59% 5.14%
PODD Insulet Corporation Buy 9.75% 11.4%
MGNX MacroGenics, Inc. Buy 9.5% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.76% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.04% 27.5%
NVCR NovoCure Limited Buy 7.62% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.38% -2.56%
STAA STAAR Surgical Company Sell -3.64% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.73% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.76%
CERS Cerus Corporation Sell -3.99% 2.84%
The percentage of cash held in the portfolio is: 49.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.84% -1.69%
AGEN Agenus Inc. Buy 5.93% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.37% 1.71%
PODD Insulet Corporation Buy 9.69% 10.8%
MGNX MacroGenics, Inc. Buy 9.34% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.7% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.47% 33.75%
NVCR NovoCure Limited Buy 7.47% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.26%
STAA STAAR Surgical Company Sell -3.62% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.26% 14.88%
VREX Varex Imaging Corporation Sell -3.98% 2.99%
CERS Cerus Corporation Sell -3.98% 2.84%
The percentage of cash held in the portfolio is: 48.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.35% -9.62%
AGEN Agenus Inc. Buy 5.55% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.45% 3.43%
PODD Insulet Corporation Buy 9.33% 7.2%
MGNX MacroGenics, Inc. Buy 9.01% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.51% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.45% 33.96%
NVCR NovoCure Limited Buy 7.3% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.28% 15.41%
STAA STAAR Surgical Company Sell -3.59% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.7% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.41%
VREX Varex Imaging Corporation Sell -3.57% 12.56%
CERS Cerus Corporation Sell -3.91% 4.27%
The percentage of cash held in the portfolio is: 46.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.22% 3%
CARA Cara Therapeutics, Inc. Buy 5.67% -6.12%
AGEN Agenus Inc. Buy 5.47% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.66% 4.57%
PODD Insulet Corporation Buy 9.34% 5.05%
MGNX MacroGenics, Inc. Buy 8.67% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.44% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.24% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.89% -3.01%
NVCR NovoCure Limited Buy 7.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.69% 0%
CDMO Avid Bioservices, Inc. Sell -3.3% 16.54%
STAA STAAR Surgical Company Sell -3.8% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.41% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
The percentage of cash held in the portfolio is: 48.43%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.91% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.6% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.41%
AGEN Agenus Inc. Buy 5.48% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.34% 5.72%
MGNX MacroGenics, Inc. Buy 8.95% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.74% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.4% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.08% 0%
NVCR NovoCure Limited Buy 8.05% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.78% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.82% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.65% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.08% 1.42%
The percentage of cash held in the portfolio is: 50.51%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.71% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.07% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 58.46%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.51% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.63% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.8% 0%
AGEN Agenus Inc. Buy 5.8% 0%
The percentage of cash held in the portfolio is: 71.57%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.76% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0%
ORGO Organogenesis Holdings Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 82.71%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 24.66%
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.69% 25.56%
The percentage of cash held in the portfolio is: 102.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 4.43%
CYH Sell All -1.57%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings